Approaching Uveitic Retinal Detachments - Summary - MDSpire

Approaching Uveitic Retinal Detachments

  • By

  • Sruthi Arepalli, MD

  • July 1, 2026

  • 8 min

Share

Objective:

To discuss the challenges and considerations in managing retinal detachments in patients with uveitis, particularly focusing on surgical planning and inflammation control.

Approach:
  • Surgical Planning: Careful perioperative and intraoperative planning is essential due to the complexity of detachments in uveitic patients, which often present with higher rates of proliferative vitreoretinopathy.
  • Inflammation Control: Aggressive treatment with corticosteroids is recommended to minimize postoperative inflammation, especially in cases with active uveitis.
  • Preoperative Assessment: Utilization of imaging techniques like widefield fundus photography and enhanced-depth imaging optical coherence tomography is crucial to accurately characterize detachments.
  • Tamponade Selection: The choice of tamponade (gas or silicone oil) should be based on the status of the contralateral eye and the specific characteristics of the detachment.
Key Findings:
  • Uveitic patients have higher rates of proliferative vitreoretinopathy (PVR) and worse surgical outcomes compared to non-uveitic patients.
  • Active inflammation is present in 46% of uveitic patients undergoing retinal detachment surgery.
  • Exudative detachments are rare in well-controlled intraocular inflammation.
Interpretation:

Setting appropriate expectations for surgical outcomes is crucial due to the complexities associated with uveitic retinal detachments.

Limitations:
  • Characterization of retinal detachments can be difficult preoperatively due to the presence of tiny retinal breaks, particularly in eyes with intermediate or posterior uveitis.
  • Cataract progression can complicate visualization during surgery, necessitating careful planning.
Conclusion:

Effective management of uveitic retinal detachments requires a multifaceted approach that includes careful surgical planning and aggressive inflammation control.

Original Source(s)

Related Content